Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| At Risk Persons | 1 |
| Autism Spectrum Disorders | 1 |
| Clinical Diagnosis | 1 |
| Effect Size | 1 |
| Genetics | 1 |
| Identification | 1 |
| Infants | 1 |
| Language Skills | 1 |
| Measures (Individuals) | 1 |
| Mental Disorders | 1 |
| Neurodevelopmental Disorders | 1 |
| More ▼ | |
Source
| Grantee Submission | 1 |
Author
| Desjardins, Christopher D. | 1 |
| Doyle, Colleen M. | 1 |
| Elison, Jed T. | 1 |
| Helwig, Nathaniel E. | 1 |
| Jacob, Suma | 1 |
| Lasch, Carolyn | 1 |
| Vollman, Elayne P. | 1 |
| Wolff, Jason J. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
| Minnesota | 1 |
Laws, Policies, & Programs
Assessments and Surveys
| MacArthur Bates Communicative… | 1 |
What Works Clearinghouse Rating
Peer reviewed
Download full text
Direct linkDoyle, Colleen M.; Lasch, Carolyn; Vollman, Elayne P.; Desjardins, Christopher D.; Helwig, Nathaniel E.; Jacob, Suma; Wolff, Jason J.; Elison, Jed T. – Grantee Submission, 2021
Background: To advance early identification efforts, we must detect and characterize neurodevelopmental sequelae of risk among population-based samples early in development. However, variability across the typical-to-atypical continuum and heterogeneity within and across early emerging psychiatric/neurodevelopmental disorders represent fundamental…
Descriptors: Clinical Diagnosis, Screening Tests, Genetics, Sampling
